Unspecific elevation of plasma troponin-T and CK-MB after coronary surgery

L-G Dahlin1, B Kågedal, E Nylander

  • 1Department of Cardiothoracic Surgery, University Hospital, Linköping, Sweden. Lars-Goran.Dahlin@lio.se

Insights

Cardiac surgery patients without permanent heart damage show significant early elevations in troponin-T and creatine kinase-MB (CK-MB). These unspecific marker releases occur during critical evaluation periods after coronary artery bypass grafting.

Area of Science:

  • Cardiology
  • Biochemistry
  • Cardiac Surgery

Background:

  • Elevated biochemical markers of myocardial injury are common post-cardiac surgery.
  • A portion of these elevations is attributed to release unrelated to permanent myocardial damage.
  • The characteristics of this 'diagnostic noise' are not well understood.

Purpose of the Study:

  • To investigate the magnitude and temporal profile of biochemical marker release in cardiac surgery patients without permanent myocardial injury.
  • To characterize the 'diagnostic noise' in troponin-T and creatine kinase-MB (CK-MB) levels post-coronary artery bypass grafting (CABG).

Main Methods:

  • Utilized unique troponin-T release kinetics to identify patients with no or minimal permanent myocardial injury after CABG with cardiopulmonary bypass (CPB).
  • Blood samples were collected pre-surgery and at multiple time points up to postoperative day 4.
  • Identified a subgroup (n=77) with normalized troponin-T by day 4 and no ECG changes indicative of injury.

Main Results:

  • In the selected subgroup, troponin-T peaked at 3 hours post-aortic unclamping (2.08 ± 1.42 µg/l).
  • Creatine kinase-monobasic (CK-MB) peaked at 8 hours post-aortic unclamping (28.6 ± 11.3 µg/l).
  • These substantial early elevations occurred despite no or minimal permanent myocardial injury.

Conclusions:

  • Significant early elevations in plasma CK-MB and troponin-T are observed in CABG patients without permanent myocardial injury.
  • This unspecific marker release is most pronounced during timeframes typically used to assess myocardial protection strategies or revascularization procedures.
  • Findings highlight the need to consider non-specific marker release when interpreting results after cardiac surgery.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...